Novocure stock advanced, but pulled back from massive gains after the FDA signed off on its cancer treatment device.
ASML extends losses after cutting sales guidance, Nvidia stock rises, and third-quarter earnings at Morgan Stanley top ...
Novocure Ltd (NVCR) is up more than +11% after the US FDA approved the company’s Optune Lua to treat metastatic non-small cell lung cancer in adults who have progressed on or after a platinum-based ...